Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant

Influenza vaccines are usually non-adjuvanted but addition of adjuvant may improve immunogenicity and permit dose-sparing, critical for vaccine supply in the event of an influenza pandemic. The aim of this first-in-man study was to determine the effect of delta inulin adjuvant on the safety and immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, David L., Sajkov, Dimitar, Honda-Okubo, Yoshikazu, Wilks, Samuel H., Aban, Malet, Barr, Ian G., Petrovsky, Nikolai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949042/
https://www.ncbi.nlm.nih.gov/pubmed/27342914
http://dx.doi.org/10.1016/j.vaccine.2016.05.071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949042/
https://www.ncbi.nlm.nih.gov/pubmed/27342914
http://dx.doi.org/10.1016/j.vaccine.2016.05.071

Ejemplares similares